Food Additives and Contaminants Part A-Chemistry Analysis Control Exposure & Risk Assessment, published by Taylor & Francis Ltd, is a leading journal in the field of food science, toxicology, and public health. With an ISSN of 1944-0049 and an E-ISSN of 1944-0057, this esteemed publication has established itself as a vital resource for researchers and professionals involved in the analysis and regulation of food additives and contaminants. Since its inception and through its converged years from 2008 to 2012 and again from 2014 to 2023, the journal has maintained an impactful presence, notably achieving a Q2 ranking in diverse categories including Chemistry (miscellaneous) and Food Science, alongside commendable standings in Health and Environmental Health. The journal’s mission is to foster high-quality research by providing a platform for critical studies related to chemical analysis, exposure assessments, and risk management in food safety. By prioritizing engaging, peer-reviewed content, it aims to enhance understanding and mitigate risks associated with food additives, making it an indispensable tool for academics, practitioners, and policymakers alike.

ACS Chemical Health & Safety, published by the American Chemical Society, serves as a vital resource in the field of chemical health and safety. With the ISSN 1871-5532 and E-ISSN 1878-0504, this journal focuses on advancing knowledge regarding safety practices in chemical research and industry, promoting the development of safer practices and technologies. It holds a respectable position with a 2023 categorization of Q3 in Chemical Health and Safety, Q2 in miscellaneous Chemistry, and Q3 in Public Health, Environmental and Occupational Health. Positioned in the United States, ACS Chemical Health & Safety is accessible through various platforms, ensuring that the latest research reaches a wide audience. As the journal converges years from 2006 to 2024, it continuously aims to disseminate high-quality research articles that enhance the understanding of hazards and risk mitigation strategies. By providing critical insights and fostering a culture of safety, this journal plays a crucial role in the ongoing discourse among researchers, professionals, and students in the domain of chemical sciences.

Biotechnology and Genetic Engineering Reviews is a prominent journal published by Taylor & Francis Ltd, specializing in the rapidly evolving fields of biotechnology and genetic engineering. Since its inception in 1984, this journal has served as a critical platform for researchers and professionals to disseminate groundbreaking scientific findings, review methodologies, and discuss emerging trends within the domain. With a substantial track record of convergence in its publication history from various years, it currently holds Q2 rankings in both Bioengineering and Biotechnology, alongside a Q3 ranking in Molecular Biology for 2023. Its dedication to quality research is reflected in its Scopus rankings, which position the journal favorably within the competitive landscape of biochemistry and molecular biology. Although it is not an open-access journal, Biotechnology and Genetic Engineering Reviews remains committed to providing accessible insights to the global scientific community, making it an invaluable resource for students, academics, and industry professionals keen on advancing their knowledge in these crucial fields.

Mycotoxin Research, published by Springer Heidelberg, is a vital interdisciplinary journal dedicated to the exploration and study of mycotoxins, their impacts on health and environment, as well as strategies for mitigation. With a solid presence in the fields of Biotechnology, Microbiology, and Toxicology, it has earned a respectable Q3 ranking and continues to facilitate the dissemination of impactful research from 1985 through to 2024. The journal caters to a diverse audience, including researchers, professionals, and students, providing a platform for original research articles, reviews, and case studies that contribute to the understanding and management of mycotoxins. Although it does not offer open-access options, the journal remains a critical resource, engaging its readers with cutting-edge findings and advancements that shape the future of health and safety regarding mycotoxin exposure. With Scopus rankings reflecting its relevance—44th in Toxicology, 113th in Biotechnology, and 71st in Microbiology—Mycotoxin Research stands as an essential publication for anyone dedicated to advancing knowledge in these critical scientific domains.

BIOTECHNOLOGY LAW REPORT, published by MARY ANN LIEBERT, INC, serves as a pivotal platform for professionals and researchers engaged in the intersection of biotechnology and law. This esteemed journal, with ISSN 0730-031X and E-ISSN 1557-8704, provides critical insights into legal issues and regulatory developments surrounding biotechnological innovations. Covering a diverse range of topics from intellectual property rights to environmental law, the journal aims to foster informed dialogue and policy advancements in a rapidly evolving field. Although it currently stands in the Q4 category for both Biotechnology and Management, Monitoring, Policy and Law, the relevance of its content persists alongside its significant contributions from industry experts and academics. Published in the United States, the journal is committed to offering comprehensive coverage of pertinent themes, despite limited open access options. As it converges its publication years towards the future, BIOTECHNOLOGY LAW REPORT remains crucial for those navigating the complexities of biotechnology legislation and its global implications.

BRITISH JOURNAL OF BIOMEDICAL SCIENCE is a distinguished peer-reviewed journal dedicated to publishing high-quality research in the field of biomedical science. Published by FRONTIERS MEDIA SA, this journal aims to advance knowledge in essential disciplines such as biochemistry, immunology, microbiology, and infectious diseases. Since its inception in 1993, the journal has maintained a solid reputation, achieving notable rankings across multiple Scopus categories, including Q2 in Biochemistry (medical) and Q3 in Clinical Biochemistry and Infectious Diseases. With an emphasis on open access, it facilitates the widespread dissemination of scientific knowledge, ensuring that researchers, professionals, and students can access cutting-edge studies and findings essential for driving innovation in medical and clinical practices. The journal's rigorous editorial standards and commitment to scientific excellence make it an invaluable resource for anyone looking to stay at the forefront of research in biomedical sciences.

ELECTROMAGNETIC BIOLOGY AND MEDICINE, published by Taylor & Francis Inc, is a pioneering journal that delves into the intricate relationships between electromagnetic fields and biological systems. With an ISSN of 1536-8378 and an E-ISSN of 1536-8386, this esteemed publication has been serving the scientific community since its inception in 1982. As a vital resource in the fields of biophysics and medical sciences, it is categorized in the Q3 quartile for both Biophysics and Medicine (miscellaneous) as of 2023, reflecting its significant contributions and robust research output. With Scopus rankings indicating a 61st percentile in Medicine and a 44th percentile in Biophysics, this journal is instrumental for researchers, professionals, and students seeking to explore the multifaceted applications of electromagnetic phenomena in health and medicine. This journal offers access options tailored to enhance visibility and dissemination of research, emphasizing its commitment to advancing knowledge and fostering innovation in this interdisciplinary domain.

FOOD AND DRUG LAW JOURNAL is a vital publication dedicated to the intersection of law, public health, and pharmaceutical regulations. Established by the Food Drug Law Institute, this journal serves as an essential resource for legal practitioners, regulatory officials, and researchers focused on the complexities of food and drug legislation. While the journal has not yet achieved open access status, it remains a respected platform for scholarly discourse, reflected in its H-Index and quartile rankings, which place it in Q3 for Law and Q4 in several other relevant fields. Covering diverse topics related to the legal frameworks governing food and drug safety from 1992 to 2018 and continuing its impactful publication from 2021 to 2023, this journal provides critical insights into emerging legal challenges and compliance assurance in the domains of pharmacology and public health. As a publication with a distinct focus on these specialized areas, it aims to advance understanding and influence policy-making, making it a significant asset for professionals and academics alike.

RISK ANALYSIS is a premier journal published by Wiley, focusing on the critical intersection of safety, risk, reliability, and quality within the fields of engineering and physiology. With a strong standing reflected in its Q1 category ranking in Safety, Risk, Reliability and Quality and Q2 in Physiology (medical), this journal is a vital resource for researchers, professionals, and students eager to stay informed on the latest methodologies, theories, and applications surrounding risk assessment and management. Since its inception in 1981, RISK ANALYSIS has been instrumental in shaping the discourse in its fields, garnering a robust reputation verified by its high rankings on Scopus, where it is positioned in the 85th percentile in Safety and the 77th percentile in Medicine. Though it does not currently offer Open Access options, the journal remains essential for those committed to advancing their understanding of risks associated with complex systems. For more insights, RISK ANALYSIS is available to readers throughout its converged years extending to 2024, solidifying its role as a foundational journal for impactful research.

ENGINEERING IN LIFE SCIENCES, published by Wiley, is a pivotal journal for professionals, researchers, and students dedicated to advancing the interdisciplinary fields of bioengineering, biotechnology, and environmental engineering. With an ISSN of 1618-0240 and an E-ISSN of 1618-2863, this journal has established itself as a reputable platform for disseminating innovative research findings and breakthroughs in engineering applications within the life sciences. Currently holding a prestigious Q2 ranking in multiple categories, including bioengineering and environmental engineering, it reflects a strong commitment to high-quality, impactful research (Scopus ranks: Environmental Science - Rank #61/197, Biochemistry, Genetics and Molecular Biology - Rank #112/311). The journal spans contributions from 2004 to 2024, ensuring a comprehensive archiving of evolving scientific discourse. Although it does not currently offer open access, its curated articles are accessible through institutional and single-article purchases, providing valuable insights and updates for the academic community. Join us in shaping the future of engineering within life sciences and stay informed on critical advancements that are driving innovation across multiple disciplines.